Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
3.520
+0.020 (0.57%)
At close: Nov 6, 2026, 4:00 PM EST
3.510
-0.010 (-0.28%)
Pre-market: Nov 9, 2026, 6:03 AM EST
Recursion Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 |
| 18.55 | 7.67 | 6.47 | 35.54 | 5.18 | 19.22 | 14.75 | 4.55 | 26.08 | 14.42 | 13.79 | 10.89 | 10.53 | 11.02 | 12.13 | 13.68 | 13.16 | 7.67 | 5.33 | 2.53 | |
Revenue Growth (YoY) | 258.49% | -60.10% | -56.11% | 681.74% | -80.16% | 33.34% | 6.89% | -58.26% | 147.62% | 30.86% | 13.68% | -20.36% | -19.96% | 43.56% | 127.53% | 439.91% | 419.34% | 201.06% | 108.16% | -5.87% |
Cost of Revenue | 109.17 | 101.11 | 100.39 | 110.22 | 135.75 | 148.8 | 151.46 | 111.13 | 86.68 | 83.13 | 78.73 | 79.36 | 80.88 | 64.44 | 59.13 | 54.82 | 56.25 | 52.67 | 40.24 | 48.29 |
Gross Profit | -90.62 | -93.44 | -93.91 | -74.68 | -130.57 | -129.57 | -136.72 | -106.58 | -60.6 | -68.71 | -64.93 | -68.47 | -70.35 | -53.43 | -46.99 | -41.14 | -43.09 | -44.99 | -34.91 | -45.76 |
Selling, General & Admin | 32.56 | 41.53 | 34.59 | 42.17 | 41.63 | 46.65 | 48.69 | 77.19 | 37.76 | 31.83 | 31.41 | 31.65 | 29.2 | 28.29 | 21.71 | 22.64 | 19.49 | 21.2 | 21.07 | 19.2 |
Operating Expenses | 32.56 | 41.53 | 34.59 | 42.17 | 41.63 | 46.65 | 48.69 | 77.19 | 37.76 | 31.83 | 31.41 | 31.65 | 29.2 | 28.29 | 21.71 | 22.64 | 19.49 | 21.2 | 21.07 | 19.2 |
Operating Income | -123.18 | -134.97 | -128.51 | -116.85 | -172.2 | -176.23 | -185.41 | -183.77 | -98.35 | -100.54 | -96.34 | -100.12 | -99.55 | -81.72 | -68.7 | -63.79 | -62.57 | -66.19 | -55.98 | -64.96 |
Interest Expense | -0.27 | -0.31 | -0.35 | - | -0.83 | -0.48 | -0.51 | -0.61 | -0.55 | -0.39 | -0.02 | -0.03 | -0.03 | -0.03 | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
Interest & Investment Income | 4.82 | 5.31 | 5.96 | 6.26 | 5.54 | 5.44 | 5.56 | 4.62 | 3.83 | 3.27 | 4.05 | 4.52 | 4.98 | 4.96 | 4.66 | 3.68 | 1.83 | 0.65 | 0.09 | 0.02 |
Other Non Operating Income (Expenses) | -0.39 | -1.04 | 0.78 | -6.03 | 5.25 | -0.63 | -16.33 | 0.85 | -0.59 | -0.39 | 0.16 | -2.62 | 1.58 | 0.06 | -0.1 | -0.18 | 0.31 | -0.01 | -0.07 | 0.03 |
EBT Excluding Unusual Items | -119.01 | -131.01 | -122.11 | -116.62 | -162.25 | -171.9 | -196.69 | -178.9 | -95.68 | -98.06 | -92.15 | -98.25 | -93.02 | -76.73 | -64.16 | -60.3 | -60.45 | -65.56 | -55.98 | -64.93 |
Merger & Restructuring Charges | - | - | - | 8.52 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Asset Writedown | - | - | - | - | - | - | -5.96 | - | - | - | - | 1.19 | - | - | -1.17 | 2.81 | - | - | - | - |
Pretax Income | -119.01 | -131.01 | -122.11 | -108.1 | -162.25 | -171.9 | -202.65 | -178.9 | -95.68 | -98.06 | -92.15 | -97.06 | -93.02 | -76.73 | -65.33 | -57.49 | -60.45 | -65.56 | -55.98 | -64.93 |
Income Tax Expense | 0.03 | -0 | -4.6 | 0.02 | 0 | - | -0.16 | 0.01 | 0.17 | -0.52 | -0.78 | -4.06 | - | - | - | - | - | - | - | - |
Net Income | -119.04 | -131.01 | -117.5 | -108.12 | -162.25 | -171.9 | -202.49 | -178.91 | -95.84 | -97.54 | -91.37 | -93 | -93.02 | -76.73 | -65.33 | -57.49 | -60.45 | -65.56 | -55.98 | -64.93 |
Net Income to Common | -119.04 | -131.01 | -117.5 | -108.12 | -162.25 | -171.9 | -202.49 | -178.91 | -95.84 | -97.54 | -91.37 | -93 | -93.02 | -76.73 | -65.33 | -57.49 | -60.45 | -65.56 | -55.98 | -64.93 |
Net Income Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding (Basic) | 543 | 532 | 529 | 527 | 447 | 417 | 403 | 336 | 283 | 242 | 236 | 223 | 214 | 201 | 192 | 186 | 173 | 172 | 171 | 169 |
Shares Outstanding (Diluted) | 543 | 532 | 529 | 527 | 447 | 417 | 403 | 336 | 283 | 242 | 236 | 223 | 214 | 201 | 192 | 186 | 173 | 172 | 171 | 169 |
Shares Change (YoY) | 21.48% | 27.58% | 31.41% | 56.75% | 58.18% | 72.32% | 70.65% | 50.58% | 31.85% | 20.25% | 23.17% | 20.19% | 23.58% | 16.96% | 12.26% | 9.62% | 2.91% | 24.47% | 640.98% | 669.39% |
EPS (Basic) | -0.22 | -0.25 | -0.22 | -0.21 | -0.36 | -0.41 | -0.50 | -0.53 | -0.34 | -0.40 | -0.39 | -0.42 | -0.43 | -0.38 | -0.34 | -0.31 | -0.35 | -0.38 | -0.33 | -0.38 |
EPS (Diluted) | -0.22 | -0.25 | -0.22 | -0.21 | -0.36 | -0.41 | -0.50 | -0.53 | -0.34 | -0.40 | -0.39 | -0.42 | -0.43 | -0.38 | -0.34 | -0.31 | -0.35 | -0.38 | -0.33 | -0.38 |
EPS Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Additional Metrics
Fiscal Quarter | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -77.81 | -105.99 | -81.36 | -47.32 | -117.6 | -79.57 | -133.79 | -116.73 | -63.79 | -83.4 | -108.95 | -76.14 | -73.67 | -71.44 | -78.49 | -52.73 | -62.8 | -78.1 | 73.05 | -65.62 |
Free Cash Flow Per Share | -0.14 | -0.20 | -0.15 | -0.09 | -0.26 | -0.19 | -0.33 | -0.35 | -0.23 | -0.34 | -0.46 | -0.34 | -0.34 | -0.35 | -0.41 | -0.28 | -0.36 | -0.45 | 0.43 | -0.39 |
Gross Margin | - | - | - | -210.13% | - | - | - | - | -232.33% | - | - | - | - | - | - | - | - | - | - | - |
Operating Margin | -663.95% | -1759.69% | -1985.55% | -328.80% | -3327.58% | -916.75% | -1257.46% | -4042.41% | -377.10% | -697.39% | -698.42% | -919.27% | -945.13% | -741.72% | -566.14% | -466.42% | -475.48% | -862.54% | -1049.71% | -2564.55% |
Profit Margin | -641.63% | -1708.02% | -1815.58% | -304.24% | -3135.32% | -894.23% | -1373.26% | -3935.46% | -367.46% | -676.56% | -662.41% | -853.88% | -883.10% | -696.43% | -538.38% | -420.39% | -459.31% | -854.31% | -1049.67% | -2563.48% |
Free Cash Flow Margin | -419.43% | -1381.89% | -1257.09% | -133.15% | -2272.52% | -413.92% | -907.35% | -2567.71% | -244.56% | -578.49% | -789.86% | -699.15% | -699.37% | -648.41% | -646.87% | -385.54% | -477.23% | -1017.70% | 1369.70% | -2590.68% |
EBITDA | -106.64 | -116.8 | -108.83 | -97.37 | -151.16 | -152.38 | -166.08 | -170.82 | -91.16 | -91.58 | -88.96 | -92.57 | -91.97 | -76.17 | -64.97 | -60.57 | -59.58 | -63.41 | -53.21 | -62.72 |
EBITDA Margin | - | - | - | -273.99% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
D&A For EBITDA | 16.54 | 18.17 | 19.67 | 19.48 | 21.04 | 23.85 | 19.33 | 12.95 | 7.2 | 8.97 | 7.38 | 7.55 | 7.58 | 5.54 | 3.73 | 3.21 | 2.99 | 2.79 | 2.77 | 2.24 |
EBIT | -123.18 | -134.97 | -128.51 | -116.85 | -172.2 | -176.23 | -185.41 | -183.77 | -98.35 | -100.54 | -96.34 | -100.12 | -99.55 | -81.72 | -68.7 | -63.79 | -62.57 | -66.19 | -55.98 | -64.96 |
Revenue as Reported | 18.55 | 7.67 | 6.47 | 35.54 | 5.18 | 19.22 | 14.75 | 4.55 | 26.08 | 14.42 | 13.79 | 10.89 | 10.53 | 11.02 | 12.13 | 13.68 | 13.16 | 7.67 | 5.33 | 2.53 |